DBV Technologies S.A.
DBVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001613780
In the last 90 days, DBV Technologies S.A. insiders filed 0 open-market purchases and 1 sale; 78 institutions reported holding it in 13F filings for Q2 2026, worth $345.7M in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesDBVTF
13F holders, Q4 2022
Institutional positions in DBV Technologies S.A. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +2 vs. Q3 2022
- Shares held
- 44.4M
- +9.90M (+28.6%) vs. Q3 2022
- Total value
- $68.0M
- +$6.85M (+11.2%) vs. Q3 2022
- New holders
- 5
- 8 more added
- Sold out
- 3
- 7 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DBVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $345.7M |
| Q1 2026 | 71 | $433.6M |
| Q4 2025 | 52 | $302.1M |
| Q3 2025 | 33 | $65.2M |
| Q2 2025 | 29 | $66.2M |
| Q1 2025 | 16 | $16.8M |
| Q4 2024 | 18 | $8.46M |
| Q3 2024 | 24 | $11.3M |
| Q2 2024 | 30 | $13.7M |
| Q1 2024 | 33 | $28.3M |
| Q4 2023 | 40 | $35.9M |
| Q3 2023 | 38 | $60.4M |
| Q2 2023 | 36 | $87.4M |
| Q1 2023 | 34 | $71.3M |
| Q4 2022 | 38 | $68.0M |
| Q3 2022 | 36 | $61.1M |
| Q2 2022 | 38 | $66.8M |
| Q1 2022 | 31 | $32.9M |
| Q4 2021 | 41 | $34.7M |
| Q3 2021 | 51 | $179.8M |
| Q2 2021 | 48 | $201.5M |
| Q1 2021 | 44 | $197.5M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding DBV Technologies S.A.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 200 | $0 | 0.00% | 00.0% | Unchanged |
| TCI Wealth Advisors, Inc. | 20 | $31 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 65 | $99 | 0.00% | 00.0% | Unchanged |
| Annapolis Financial Services, LLC | 270 | $413 | 0.00% | 00.0% | Unchanged |
| Mark Sheptoff Financial Planning, LLC | 300 | $459 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 855 | $1.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 631 | $1.00K | 0.00% | +335+113.2% | Added |
| Bank of America Corp | 1,978 | $3.03K | 0.00% | +134+7.3% | Added |
| Barclays PLC | 2,012 | $3.08K | 0.00% | +1,121+125.8% | Added |
| Group One Trading, L.P. | 2,477 | $3.79K | 0.00% | −349−12.3% | Reduced |
| Cutler Group LP | 3,100 | $4.00K | 0.00% | 00.0% | Unchanged |
| Advisory Services Network, LLC | 4,000 | $6.12K | 0.00% | +4,000 | New |
| Federation des caisses Desjardins du Quebec | 4,255 | $6.51K | 0.00% | 00.0% | Unchanged |
| Heritage Wealth Advisors | 6,000 | $9.18K | 0.00% | 00.0% | Unchanged |
| RSM US Wealth Management LLC | 10,000 | $15.3K | 0.00% | +10,000 | New |
| Tower Research Capital LLC (TRC) | 10,307 | $16.0K | 0.00% | +5,998+139.2% | Added |
| Two Sigma Investments, LP | 13,625 | $20.8K | 0.00% | −22,295−62.1% | Reduced |
| Commonwealth Equity Services, LLC | 14,700 | $22.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 14,400 | $22.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 23,666 | $36.0K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 24,053 | $36.8K | 0.00% | −33,846−58.5% | Reduced |
| Janney Montgomery Scott LLC | 25,700 | $39.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 35,010 | $53.6K | 0.00% | +35,010 | New |
| Cowen and Company, LLC | 50,986 | $78.0K | 0.01% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 54,497 | $83.4K | 0.00% | +16,469+43.3% | Added |
| Commodore Capital LP | 92,687 | $142.0K | 0.02% | +92,687 | New |
| Optiver Holding B.V. | 104,599 | $160.0K | 0.01% | +84,427+418.5% | Added |
| Nan Fung Group Holdings Ltd | 370,950 | $567.6K | 0.39% | 00.0% | Unchanged |
| Morgan Stanley | 495,838 | $758.6K | 0.00% | −35,921−6.8% | Reduced |
| Millennium Management LLC | 871,996 | $1.33M | 0.00% | +305,562+53.9% | Added |
| BlackRock Inc. | 1,054,676 | $1.61M | 0.00% | +12,145+1.2% | Added |
| Ameriprise Financial Inc | 1,244,435 | $1.91M | 0.00% | −49,763−3.8% | Reduced |
| Boxer Capital, LLC | 1,450,000 | $2.22M | 0.12% | −684,598−32.1% | Reduced |
| Ra Capital Management, L.P. | 1,958,957 | $3.00M | 0.06% | −1,765,783−47.4% | Reduced |
| Vivo Capital, LLC | 2,708,875 | $4.14M | 0.50% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 7,064,964 | $10.8M | 1.71% | 00.0% | Unchanged |
| Braidwell LP | 12,107,785 | $18.5M | 0.62% | +12,107,785 | New |
| Baker Bros. Advisors LP | 14,614,264 | $22.4M | 0.13% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −181,050−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −4,992−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −1,861−100.0% | Sold out |